The authors discuss the creation of a “culture of safety,” brought about in part by a confidential error-reporting system. Their experience has the potential to encourage employees to report medication errors without fear of blame.
You are here
P&T® Journal contents for November 2007
Improving the Reporting of Medication Errors and Adverse Events at the Veterans Affairs–New York Harbor Healthcare System
How and whether to treat older children and adolescents with elevated cardiac risk factors presents a dilemma for health care providers. The authors discuss screening, the problem of compliance with lifestyle modifications, and the ramifications of statin therapy for these young patients.
Foot care programs decrease the risk of foot ulcers by 13-fold. The authors found that the more frequently diabetic patients checked their feet, the greater their knowledge of their condition.
Presentations cover glycemic control to reduce macrovascular events; the need to achieve LDL-cholesterol goals; and the beneficial effects of sitagliptin/metformin on blood glucose. Forthcoming products from Sanofi-Aventis are also summarized.
Topics include amlodipine/olmesartan medoxomil (Azor) for hypertension; dexrazoxane (Totect) after chemotherapy; and a topical thrombin (Evithrom) to help control bleeding during surgery.